GENEVA, June 26 -- NORTHRIDGE HEALTH GROUP (HONG KONG) CO., LIMITED filed a patent application (CN2025/139680) for “PTPN2/PTP1B DEGRADERS AND THERAPEUTIC METHOD THEREOF”. With publication no. WO/2026/119184, here are the other details related to the patent application:
Kind: Initial Publication without ISR [A2]
IPC: none
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....